United States
US 12,697,375 B2
Treatment of chronic obstructive pulmonary disease using botulinum toxin
US 12,697,375 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Penland Foundation. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Penland Foundation
- Inventors
- Roland M. Williams
- Publication date
- 2026-08-04
- Filing date
- 2022-11-15
- Document type
- B2 Granted patent
- Also written as
- US 12,697,375 B2 · US12697375 · 12697375
Abstract
Botulinum toxin for use in treating chronic obstructive pulmonary disease (COPD) in a patient in need thereof is provided. The treatment comprises administering botulinum toxin to the patient. The botulinum toxin may be administered by subcutaneous or intradermal injection. The subcutaneous or intradermal injection may be administered to and/or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, and/or a sacral nerve of the patient.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free